Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European Society of Hypertension position paper on renal denervation 2021
Roland E. Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
Journal of Hypertension (2021) Vol. 39, Iss. 9, pp. 1733-1741
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1507
Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial
Kazuomi Kario, Yoshiaki Yokoi, Keisuke Okamura, et al.
Hypertension Research (2021) Vol. 45, Iss. 2, pp. 221-231
Open Access | Times Cited: 115
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 96
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
Tzung‐Dau Wang, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2022) Vol. 38, Iss. 3, pp. 225-325
Closed Access | Times Cited: 88
Diagnosis and treatment of arterial hypertension 2021
Christian Ott, Roland E. Schmieder
Kidney International (2021) Vol. 101, Iss. 1, pp. 36-46
Closed Access | Times Cited: 73
Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension
Giuseppe Mancia, Francesco P. Cappuccio, Michel Burnier, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 3, pp. 251-268
Open Access | Times Cited: 22
Long-Term Blood Pressure Reductions Following Catheter-Based Renal Denervation: A Systematic Review and Meta-Analysis
Gianni Sesa-Ashton, Janis M. Nolde, Ida Muente, et al.
Hypertension (2024) Vol. 81, Iss. 6
Closed Access | Times Cited: 14
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence
Andrew S.P. Sharp, Khoa N. Cao, Murray Esler, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2024) Vol. 10, Iss. 8, pp. 698-708
Open Access | Times Cited: 9
Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials
Yukako Ogoyama, Kazuhiro Tada, Makiko Abe, et al.
Hypertension Research (2021) Vol. 45, Iss. 2, pp. 210-220
Closed Access | Times Cited: 50
A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment
Kazuomi Kario, Hideaki Kagitani, Shoko Hayashi, et al.
Hypertension Research (2021) Vol. 45, Iss. 2, pp. 232-240
Open Access | Times Cited: 42
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry
Roland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2022) Vol. 9, Iss. 6, pp. 575-582
Open Access | Times Cited: 28
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
Felix Mahfoud, Giuseppe Mancia, Roland E. Schmieder, et al.
Hypertension (2023) Vol. 80, Iss. 8, pp. 1759-1770
Open Access | Times Cited: 18
Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS)
Kazuomi Kario, Hisashi Kai, Hiromi Rakugi, et al.
Hypertension Research (2024) Vol. 47, Iss. 10, pp. 2624-2632
Open Access | Times Cited: 6
New perspectives for hypertension management: progress in methodological and technological developments
Gianfranco Parati, Alexandra Gonçalves, David G. Soergel, et al.
European Journal of Preventive Cardiology (2022) Vol. 30, Iss. 1, pp. 48-60
Closed Access | Times Cited: 23
2022 Renal denervation therapy for the treatment of hypertension: a statement from the Thai Hypertension Society
Weranuj Roubsanthisuk, Sirisawat Kunanon, Pairoj Chattranukulchai, et al.
Hypertension Research (2023) Vol. 46, Iss. 4, pp. 898-912
Open Access | Times Cited: 13
The effect of renal denervation in microcirculation: focusing on coronary microvascular dysfunction
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Fotis Tatakis, et al.
Future Cardiology (2025) Vol. 21, Iss. 4, pp. 245-256
Closed Access
Evaluating Veterans' Preferences for Renal Denervation for Treatment of Difficult‐to‐Control Hypertension: A Single‐Center Survey Study
Benjamin Magod, Peter Glynn, Wesley J. Manz, et al.
Health Science Reports (2025) Vol. 8, Iss. 3
Open Access
Renal Denervation
Fosca Quarti‐Trevano, Guıdo Grassı
Updates in hypertension and cardiovascular protection (2025), pp. 367-375
Closed Access
Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
Roland E. Schmieder
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 5, pp. 1089-1096
Open Access | Times Cited: 21
Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation
Lloyd Butel-Simoes, Tatt Jhong Haw, Trent Williams, et al.
Hypertension (2023) Vol. 80, Iss. 4, pp. 685-710
Open Access | Times Cited: 11
Italian Society of Interventional Cardiology (GISE) and Italian Society of Arterial Hypertension (SIIA) Position Paper on the role of renal denervation in the management of the difficult-to-treat hypertension
Eugenio Stabile, María Lorenza Muiesan, Flavio Ribichini, et al.
Minerva Cardiology and Angiology (2024) Vol. 72, Iss. 4
Open Access | Times Cited: 4
Renal denervation in the antihypertensive arsenal – knowns and known unknowns
Franz H. Messerli, Chirag Bavishi, Jana Brguljan, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 10, pp. 1859-1875
Open Access | Times Cited: 17
Long-term follow-up of patients undergoing renal sympathetic denervation
Victor Zeijen, Lida Feyz, Rajiv Nannan Panday, et al.
Clinical Research in Cardiology (2022) Vol. 111, Iss. 11, pp. 1256-1268
Open Access | Times Cited: 16
Resistant hypertension: consensus document from the Korean society of hypertension
Sungha Park, Jinho Shin, Sang‐Hyun Ihm, et al.
Clinical Hypertension (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives
Filippo Scalise, Fosca Quarti‐Trevano, Evelina Toscano, et al.
High Blood Pressure & Cardiovascular Prevention (2024) Vol. 31, Iss. 1, pp. 7-13
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top